Difference between revisions of "Chandimali Nisansala, et al. Cancer Gene Therapy (2018) cited as Ref 273 in DOI: 10.1038/s41392-020-0110-5 (Q9536)"

@@ Property / Publication Date @@
+Timestamp +2018-01-01T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 year
Before 0
After 0
-Timestamp
++2018-01-01T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+year
 Before
 After
@@ Property / Publication Date: 2018 / rank @@
+Normal rank
@@ Property / Published In Name String @@
+Cancer Gene Therapy
@@ Property / Published In Name String: Cancer Gene Therapy / rank @@
+Normal rank
@@ Property / Volume @@
@@ Property / Volume: 26 / rank @@
+Normal rank
@@ Property / title @@
+MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells (English)
+Normal rank
@@ Property / Page(s) @@
+-304
@@ Property / Page(s): 292-304 / rank @@
+Normal rank
@@ Property / Fourth Author string @@
+Lee Jae Cheol
@@ Property / Fourth Author string: Lee Jae Cheol / rank @@
+Normal rank
@@ Property / Fifth Author string @@
+Yu Dae-Yeul
@@ Property / Fifth Author string: Yu Dae-Yeul / rank @@
+Normal rank
@@ Property / Sixth Author string @@
+Jeong Dong Kee
@@ Property / Sixth Author string: Jeong Dong Kee / rank @@
+Normal rank
@@ Property / Seventh Author string @@
+Kwon Taeho
@@ Property / Seventh Author string: Kwon Taeho / rank @@
+Normal rank

Latest revision as of 13:55, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

Language	Label	Description	Also known as
English	Chandimali Nisansala, et al. Cancer Gene Therapy (2018) cited as Ref 273 in DOI: 10.1038/s41392-020-0110-5	Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8